Olympus has launched EU-ME3, a new Endoscopic Ultrasound Processor, which addresses the needs of healthcare professionals for high-quality clear images when conducting the endoscopic ultrasound procedure.
EU-ME3 will be launched in Europe, the Middle East, Africa, parts of Asia, and Oceania within this fiscal year.
Olympus, a specialist in endoscopic ultrasound (EUS) technology, aims to use its expertise to enhance the care pathway in gastrointestinal and respiratory disease management. The technology is used for endoscopic ultrasonography, imaging to support the diagnosis of lesions in the pancreas, the bile ducts, or lesions that are located deep inside the body and are not visible with gastrointestinal endoscopes. It allows the detailed examination of pancreatitis, pancreatic cancer, and the diagnosis of cancer invasion in the stomach and the oesophagus. Endoscopic ultrasound also plays a key role in facilitating the visualisation of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for early, minimally invasive diagnosis and lung cancer staging.
Hironobu Kawano, head of endoscopic solutions division at Olympus, said: "It is said that pancreatic cancer is difficult to be detected in its early stages, and that lung cancer has the highest mortality rate among all cancers. With the launch of the EU-ME3, Olympus aims to enhance the standard of care including these diseases and to further improve the quality of life of patients.”
- Advancing the dimensions of endosonography
With the needs of healthcare professionals and patient outcomes at its core, EU-ME3 is tailored to improve a variety of procedures.
EU-ME3 provides outstanding image quality and functionality. The image quality has been substantially enhanced compared to the prior generation model (EU-ME2), providing enhanced visualisation, therefore supporting a more reliable diagnosis and treatment.
Shear Wave Quantification, a newly equipped feature for EU-ME3, also contributes to accurate diagnosis by providing quantitative information on the stiffness of tumour and inflamed lesions, which is an important factor when diagnosing the degree of pancreatitis and malignancy of pancreatic cancer during endoscopic ultrasonography.
The Endoscopic ultrasound procedure typically utilises a variety of observation modes dependent on procedure type or clinical area. Subsequently, in addition to the basic observation mode, EU-ME3 offers multiple software options for individual clinical needs, aiming to stay flexible in the selection of functions and tailor EU-ME3 depending on specialty.
Smart and customisable user settings make it easy to fulfil needs for multiple specialties and personal requirements. The backlit keyboard includes a simple, easy-to-use large touch panel and trackpad, designed to support better operability and easier cleaning.
With EU-ME3, the aim is to provide seamless workflow integration for healthcare professionals while advancing the dimensions of Endosonography for better overall patient outcome.
